Thomas Ulmer
Director/Miembro de la Junta en Aravax Pty Ltd. .
Cargos activos de Thomas Ulmer
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Aravax Pty Ltd.
 Aravax Pty Ltd. BiotechnologyHealth Technology Aravax Pty Ltd. develops treatments for peanut allergies. The company was founded in May 2015 and is headquartered in Melbourne, Australia. | Director/Miembro de la Junta | 01/11/2020 | - |
Historial de carrera de Thomas Ulmer
Antiguos cargos conocidos de Thomas Ulmer.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Director Ejecutivo | 01/04/2018 | 12/02/2020 |
| MERCK KGAA | Corporate Officer/Principal | 01/04/2012 | 01/07/2016 |
| IMMATICS N.V. | Director Financiero/CFO | 01/07/2020 | - |
Formación de Thomas Ulmer.
| University of Giessen | Masters Business Admin |
Estadísticas
Internacional
| Alemania | 5 |
| Australia | 2 |
Operativa
| Director of Finance/CFO | 1 |
| Masters Business Admin | 1 |
| Chief Executive Officer | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| IMMATICS N.V. | Health Technology |
| MERCK KGAA | Health Technology |
| Empresas privadas | 2 |
|---|---|
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
Aravax Pty Ltd.
Aravax Pty Ltd. BiotechnologyHealth Technology Aravax Pty Ltd. develops treatments for peanut allergies. The company was founded in May 2015 and is headquartered in Melbourne, Australia. | Health Technology |
- Bolsa de valores
- Insiders
- Thomas Ulmer
- Experiencia
